ANAVEX LIFE SCIENCES CORP. 10-Q filing
Filed 2026-02-09 · Report date 2025-12-31 · 2025
Filing metadata
- Accession number
- 0001731122-26-000200
- Form type
- 10-Q
- CIK
- 0001314052
- Primary document
- https://www.sec.gov/Archives/edgar/data/1314052/000173112226000200/e7289_10-q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ANAVEX LIFE SCIENCES CORP..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-6.8M | - | - |
| Net Income | $-5.7M | - | - |
| Eps Basic | -0.06 | - | - |
| Eps Diluted | -0.06 | - | - |
| Cash And Equivalents | $131.7M | - | - |
| Total Assets | $133.0M | - | - |
| Total Liabilities | $6.4M | - | - |
| Shareholders Equity | $126.6M | - | - |
| Operating Cash Flow | $-7.2M | - | - |